Work

What is the evidence for using subcutaneous apomorphine in nil by mouth Parkinson's patients in acute settings?

Year: 2026
Type: article
Abstract: Subcutaneous apomorphine is an established intervention for managing "off" episodes and motor fluctuations in Parkinson's disease, though no direct studies on nil by mouth patients in acute settings were identified. The evidence supports its use due to rapid effectiveness and practicality in non-oral scenarios.
Author: Tripdatabase
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7226010482
FWCI:
Cites:
Cited by:
Related to: 10